PCPT
From Cancer Guidelines Wiki
PCPT
Publications of this clinical trial
- Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006 Apr 19;98(8):529-34 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16622122. (compare appraisals of this publication)
- Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 2005 Jul 6;294(1):66-70 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15998892. (compare appraisals of this publication)
- Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004 May 27;350(22):2239-46 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15163773. (compare appraisals of this publication)
- Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman SM, et al. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. J Urol 2007 May;177(5):1749-52 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17437804. (compare appraisals of this publication)